Indigo Star (08373) announces its annual performance for 2024, with a net profit attributable to shareholders of 3.168 million Singapore dollars, representing a year-on-year increase of 217.12%.

07:23 26/01/2026

IndigoStar (08373) announced its full-year financial results for the year ending December 31, 2024, with a revenue of 86.431 million Singapore dollars, a year-on-year increase of 95.02%; net profit attributable to shareholders of 3.168 million Singapore dollars, a year-on-year increase of 217.12%; earnings per share of 7.92 Singapore cents.

INDIGO STAR (08373) announced its full-year performance for the year ending December 31, 2024, with revenue of 86.431 million Singapore dollars, a year-on-year increase of 95.02%; shareholders' net profit was 3.168 million Singapore dollars, a year-on-year increase of 217.12%; earnings per share was 7.92 Singapore cents.

Brokerage morning meeting highlights | Prosperity is the core, adhere to the "technology + resources" dual mainline

ASCLETIS-B (01672) announced that the first batch of subjects in the 13-week Phase II study of the oral small molecule GLP-1R agonist ASC30 for the treatment of diabetes has been dosed in the United States.

On January 23, BEKE-W (02423) spent 3 million US dollars to repurchase 492,000 shares.

Brokerage morning meeting highlights | Prosperity is the core, adhere to the "technology + resources" dual mainline

On January 23, BEKE-W (02423) spent 3 million US dollars to repurchase 492,000 shares.